![]() |
March 16, 2026
|
|
1.
|
Is IPX aware of any information concerning it that has not been announced to the market which, if known by some in the market,
could explain the recent trading in its securities?
|
|
2.
|
If the answer to question 1 is “yes”
|
|
3.
|
If the answer to question 1 is “no”, is there any other explanation that IPX may have for the recent trading in its securities?
|
|
1.
|
IperionX makes cash payments for spending upon projects under its U.S. Department of War grants.
|
|
2.
|
The U.S. Government subsequently re-imburses IperionX after these payments have been made.
|
|
3.
|
For the period to Dec 31, 2025, approximately $6.6 million in payments were incurred that were not yet reimbursed.
|
|
4.
|
Under IperionX’s accounting treatment, the Company procures equipment solely in an agency capacity on behalf of the U.S. Government. When an asset is
purchased for the U.S. Government, IperionX records a receivable representing the amount due for reimbursement, rather than recognizing the asset or related expense.
|
|
5.
|
The U.S. Government can elect to, but is not obliged to, transfer title to all or a portion of equipment or real property to IperionX at the
conclusion of the U.S. Department of War projects.
|
|
6.
|
As previously disclosed in the December 31, 2025 quarterly activities report, a balance of $46.5 million remains available for reimbursement from the
U.S. Government.
|
|
4.
|
Please confirm that the Entity is in compliance with the Listing Rules and, in particular, Listing Rule 3.1
|
|
5.
|
Approval of responses
|
|
|
Virginia
|
Tennessee
|
Utah
|
|
1092 Confroy Drive
South Boston, VA 24592
|
279 West Main Street
Camden, TN 38320
|
1782 W 2300 S
West Valley City, UT 84119
|
|
|
IperionX Limited ABN 84 618 935 372
|
|||